Skip to content
For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement.
AMIRAVOResearch Library
Cycle-length evidence

5-Amino-1MQ cycle length: what human studies ran

Not approved — research use onlyCPreclinical research
Short answer: there is no established 5-Amino-1MQ cycle length, and we found no human studies that report one.

Treatment and follow-up in human studies

No human study durations are recorded.

What has not been tested

  • On-and-off schedules or breaks between courses.
  • Repeated courses and long-term exposure beyond the periods listed.
  • 5-Amino-1MQ combined with other compounds, unless a study above says so.

Frequently asked questions

Is there an established 5-Amino-1MQ cycle length?
No. We found no human studies that report a treatment duration for 5-Amino-1MQ.
What is the longest human study of 5-Amino-1MQ?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
5-Amino-1MQ dosing reference Full research page

References

  1. Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction Diabetes, Obesity and Metabolism. 2024
  2. Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice Scientific Reports. 2022
  3. Small molecule inhibitor of nicotinamide N-methyltransferase shows anti-proliferative activity in HeLa cells Journal of Obstetrics and Gynaecology. 2021
  4. NAD(+) metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer Journal for ImmunoTherapy of Cancer. 2024
  5. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the FD&C Act (updated May 14, 2026) FDA. 2026
  6. ClinicalTrials.gov searches for 5-amino-1MQ and for nicotinamide N-methyltransferase inhibitor as interventions (0 studies returned each) ClinicalTrials.gov. 2026
  7. World Anti-Doping Code International Standard: Prohibited List 2026 WADA. 2026
  8. Emerging opportunities for nicotinamide N-methyltransferase (NNMT) inhibitor clinical translation Trends Pharmacol Sci. 2026